|
|
 |
|
Viewing report
|
|
|
|
Cadence Pharmaceuticals, Inc. (CADX) - Financial and Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 37
Cadence Pharmaceuticals, Inc. (CADX) - Financial and Strategic SWOT Analysis Review
Summary
Cadence Pharmaceuticals, Inc. (Cadence) is a biopharmaceutical company principally engaged in in-licensing, developing and commercialization of proprietary pharmaceuticals, and product candidates that are principally used in the hospital setting. Cadence focused extensively on the development of product candidates for the treatment of acute pain and fever through its extensive and focused research operations. It is developing Ofirmev as its lead product for the treatment of acute pain and fever in adults and pediatrics. Cadence has in-licensed in the US and Canadian rights to Ofirmev from Bristol-Myers Squibb Company (BMS), which sells Ofirmev product candidate in Europe and other markets under the brand name Perfalgan. It is available in the combination and also as single-ingredient prescription and over-the-counter medicines, including powder, caplet, orally-dosed liquid suspension, tablet and suppository forms The company has its operation spread across the US. Cadence is headquartered in San Diego, California, the US.
Cadence Pharmaceuticals, Inc. Key Recent Developments…
May 05, 2011 Cadence Pharmaceuticals Reports Net Loss Of $24.4m For Q1 2011
Mar 03, 2011 Cadence Reports Net Loss Of $18.8m For Q4 2009
Nov 05, 2010 Cadence Reports Net Loss Of $11.7 Million For Q3 2010
Aug 05, 2010 Cadence Reports Net Loss Of $12.2 Million For Q2 2010
May 14, 2010 Cadence Pharmaceuticals Announces Ofirmev(Tm) Nda Action Date Of November 4, 2010
This comprehensive SWOT profile of Cadence Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
ADVENTRX Pharmaceuticals (ANX) - Financial and Strategic SWOT Analysis Review
MAP Pharmaceuticals, Inc. (MAPP) - Financial and Strategic SWOT Analysis Review
Cadence Design Systems, Inc. - SWOT Analysis
ISTA Pharmaceuticals, Inc. (ISTA) - Financial and Strategic SWOT Analysis Review
Talon Therapeutics, Inc. (TLON) - Financial and Strategic SWOT Analysis Review
Cadence Design Systems, Inc. - Strategy and SWOT Report
Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review
BioCryst Pharmaceuticals, Inc. (BCRX) - Financial and Strategic SWOT Analysis Review
Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review
Cadence Design Systems, Inc. - Strategy, SWOT, and Corporate Finance Report
|
|
|
|
